CIDP can only be reliably differentiated from clinical mimics through systematic diagnostics. Diagnostic findings guide the selection of suitable immunotherapy. Chronic inflammatory demyelinating polyneuropathy shows diverse phenotypes and is often misdiagnosed. This article summarizes the guideline-compliant diagnostic procedure, explains the role of electrophysiology and shows how variants and antibody profiles determine the choice of immunotherapy.
Autoren
- Dr. Ulf Blanke
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Polycystic ovary syndrome 2025/2026
New pathophysiology, updated diagnostics and the age of incretin mimetics
- Heart failure and type 2 diabetes
Oral semaglutide and cardiac decompensation in type 2 diabetes
- Atopic dermatitis as a door opener for an atopic cascade?
AD trajectories: Summary of current findings
- New evidence on descensus, urinary incontinence and the future of reconstruction
Urogynecology and pelvic floor surgery 2026
- Proteins in wound healing
Do special amino acids lead to success?
- Case study
Autosomal recessive polycystic kidney disease: atypical phenotype
- Current evidence, risk classes and new counseling options
Hormonal contraception and cardiovascular risk
- Acute otitis media: self-limiting course vs. "red flags"